Human monocytotropic ehrlichiosis

Human monocytic ehrlichiosis
Ehrlichia chaffeensis
Specialty	Infectious diseases

Human monocytotropic ehrlichiosis

The severity of the illness can range from minor or asymptomatic to life-threatening. CNS involvement may occur. A serious septic or toxic shock-like picture can also develop, especially in patients with impaired immunity.[5]

This disease is known to be caused by tick bites.^[6]

Tick exposure is often overlooked. For patients living in high-prevalence areas who spend time outdoors, a high degree of clinical suspicion should be employed.^{[citation needed]} Ehrlichia serologies can be negative in the acute period. Polymerase chain reaction is therefore the laboratory diagnostic tool of choice.^[7]

If ehrlichiosis is suspected, treatment should not be delayed while waiting for a definitive laboratory confirmation, as prompt doxycycline therapy has been associated with improved outcomes.^[8] Doxycycline is the treatment of choice.^{[citation needed]}

Presentation during early pregnancy can complicate treatment.

In the US, human monocytotropic ehrlichiosis occurs across the south-central, southeastern, and mid-Atlantic states, regions where both the white-tailed deer (Odocoileus virginianus) and its ectoparasite, Lone Star ticks (Amblyomma americanum), thrive.^[11][12][13]

Human monocytotropic ehrlichiosis occurs in California in Ixodes pacificus ticks and in Dermacentor variabilis ticks.^[14] Nearly 600 cases were reported to the CDC in 2006. In 2001–2002, the incidence was highest in Missouri, Tennessee, and Oklahoma, as well as in people older than 60.^[15]

• Human ewingii ehrlichiosis
• Human granulocytic anaplasmosis
• Monocyte